Creating a business case

 

For any healthcare organisation considering an MES system, there will typically be 5 to 10 people in different roles who are actively involved in the investment decision. To avoid objections and challenges further down the line, we recommend creating a business case with solid financials to express the costs, financial benefits and expected payback period.

 

Start with a baseline

A robust business case starts with a baseline, quantifying the cost of no-change. It considers the investment required for a complete MES initiative, including business change and validation. Finally, it will consider the ways in which ROI will be delivered, providing defensible figures together with expected payback periods.

Following a proven process

For organisations which are not experienced in this kind of analysis, industry specialists from CI Precision offer a consulting service to develop a detailed business case.

The team works with you, following an established process, which includes:

  • Visiting your premises and reviewing key aspects of your manufacturing process, from management vision through to working practices and constraints.
  • Analysing the issues and shortcomings in your current setup and undertaking a GAP analysis to highlight the potential for improvements.
  • Working with you to evaluate the benefits – including secondary benefits such as data analysis – from an MES system, as well as calculating the expected costs of implementing it and the ongoing costs of ownership.
  • Agreeing a phased implementation approach, to gain user confidence and rapid ROI, over a defined time period.
Ci-DMS Manufacturing Execution System

Making it specific to your business

We don’t use assumed cost figures or generalised processes; the business case is based on your business processes and your costs. It provides a credible basis for examining whether or not there is justification for moving forward with an MES.

By creating a clear, well-constructed business case, it is likely that you will have a strong justification to go ahead. However, if you find that the investment would not be justified in your particular circumstances, then you can walk away without the risk and cost of embarking on a full project.

What our customers say

Aesica Pharmaceuticals contracted CI Precision’s consultancy team to conduct a business process review aimed at analysing the benefits to be accrued from implementing a Manufacturing Execution System (MES) and the expected return on investment (ROI).

The business process analysis demonstrated that implementation of the MES Weigh and Dispense and SAP Interface modules would mitigate the risk of human error, reduce batch cycle times and improve data integrity by removing manual processes. The projected ROI payback period was impressively fast which made the investment easy to justify.


How you can meet us

Request a meeting, or find us at an exhibition